UBS/CALL/ROCHE GS/350.004/0.025/20.12.24 Share Price

Warrant

BROGOU

CH1129673666

Market Closed - Swiss Exchange 16:20:00 11/06/2024 BST
0.013 CHF +8.33% Intraday chart for UBS/CALL/ROCHE GS/350.004/0.025/20.12.24
Current year-55.17%
Date Price Change
11/06/24 0.013 +8.33%
10/06/24 0.012 +20.00%

Delayed Quote Swiss Exchange

Last update June 11, 2024 at 04:20 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
BROGOU
ISINCH1129673666
Date issued 07/10/2021
Strike 350 CHF
Maturity 20/12/2024 (188 Days)
Parity 40 : 1
Emission price 1.07 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 1.779 CHF
Lowest since issue 0.01 CHF
Spread 0.019 CHF
Spread %63.33%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
247.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+12.30%
Consensus
  1. Stock Market
  2. Warrants
  3. BROGOU Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW